peripheral nervous system drugs. cholinergic drugs muscarinic agonists muscarinic antagonists...

40
Peripheral Nervous System Drugs

Upload: mabel-rice

Post on 15-Jan-2016

237 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Peripheral Nervous System Drugs

Page 2: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Cholinergic Drugs

• Muscarinic agonists

• Muscarinic antagonists

• Ganglionic stimulants

• Ganglionic blockers

• Neuromuscular blockers

• Cholinesterase inhibitors: affects all cholinergic receptors

Page 3: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Parasympathetic Actions

Page 4: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Parasympathetic Receptors

Page 5: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Muscarinic Agonists(Parasympathomimetics)

• Limited uses:– Urinary retention– Increase GI peristalsis– Glaucoma, eye surgery

• Adverse effects– Bradycardia, hypotension– Excess saliva, cramps, diarrhea– Urinary (contra: bladder obstruction &surgery)– Asthma exacerbation

Page 6: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Muscarinic Poisoning

• Sources– Muscarinic agonists– Cholinesterase inhibitors– Mushrooms

• Symptoms– Profuse salivation, tearing, bronchospasm,

diarrhea, bradycardia, hypotension

• Treatment: atropine

Page 7: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Muscarinic Antagonists (Parasympatholytics)

• “Anticholinergics”• Agents

– Atropine: strongest, general use– Oxybutinin (Ditropan): overactive bladder– Tolerodine (Detrol): overactive bladder– Scopolamine: sedation, motion sickness– Ipratropium: lungs– Dicyclomine (Bentyl): IBS, diarrhea– Others: ophthalmic procedures, Parkinson’s

Page 8: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Atropine

• Mechanism: competitive blockade of muscarinic receptors. High doses will block nicotinic as well

• Pharmacologic effects:– Heart: increase heart rate– Exocrine Glands: decrease secretions– Relaxation of smooth muscle– Eye: mydriasis– CNS excitation

Page 9: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Atropine

• Dose dependent– Low dose

– High dose

– Glands: sweat, salivary, bronchial

– Heart– Eye

– Bladder– Intestine motility– Lung

– Stomach

Page 10: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Atropine

• Kinetics: PO, topically (eye), injection

• Therapeutic Uses– Preanesthesia– Eye surgery– Bradycardia– Intestinal hypertonicity, hypermotility– Muscarinic Agonist Poisoning

Page 11: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Adverse (Anticholinergic) Effects

• Xerostomia (Dry Mouth)• Blurred vision, photophobia• Elevation of IOP• Urinary retention• Constipation• Anhidrosis (no sweat)• Tachycardia• Asthma: secretions too thick and crusty• Dementia

Page 12: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Interactions

• Other drugs with anti-muscarinic effects– Antihistamines– Phenothiazine antipsychotics– Tricyclic antidepressants

Page 13: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Anticholinergic Toxicity

• Dry as a bone• Hot as a hare• Blind as a bat• Mad as a hatter

– **Must determine whether psychosis is real or anticholinergic

• Treatment:– Minimize absorption– Cholinesterase inhibitor

Page 14: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Cholinesterase Inhibitors

• Reversible– Neostigmine: myasthenia gravis– Physostigmine: anti-cholinergic antidote

• Irreversible– Used as insecticides– Developed in WW2 as “nerve gas”– One is used for glaucoma

Page 15: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Myasthenia Gravis

• Etiology: Antibodies against Nicotinic-M receptors

• Clinical manifestations: fatigue, muscular weakness, dyspnea

• Treatment– Cholinesterase inhibitors– Side effects: can cause accumulation of

acetylcholine and nicotinic-M and muscarinic receptors

Page 16: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Myasthenia Gravis

• Treatment– Side effects cont– Muscarinic effects– Neuromuscular blockade (toxicity)

Page 17: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Neuromuscular Blockers

• Neuromuscular Blockers– Paralytics– Repiratory depression, hypotension– Agents

• Nondepolarizing: tubocurarine, et al.• Depolarizing: succinylcholine

• Uses– Surgery– Mechanical Ventilation, ET intubation– Adjunct to ECT

Page 18: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Sympathetic Actions

Page 19: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Sympathetic Receptors

Page 20: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Adrenergic Agonists

• Activate alpha and beta receptors

• Catecholamines: – Broken down by MAO and COMT in liver and

intestine– Cannot be given orally, short half-life– Epinephrine, Norepinephrine, isoproterenol,

dopamine, dobutamine– Colorless solutions; color is sign of oxidation

Page 21: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Adrenergic Agonists

• Noncatecholamines– Can be given PO– Last longer in body– Ephedrine, phenylephrine, terbutaline

Page 22: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Receptor Specificity

• Dobutamine: Beta1

• Terbutaline: beta2

• Isoproterenol: beta1 & 2

• Epinephrine: alpha 1 & 2, beta1 & 2

• Relative selectivity– Selectivity declines as concentration rises

Page 23: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Alpha1 Stimulation• Therapeutic effects

– Vasoconstriction hemostasis– Nasal decongestion– Local anesthesia adjunct– Increase BP (intensive care, last resort)– Mydriasis

• Adverse effects– Hypertension– Necrosis– Bradycardia

Page 24: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Beta1 Activation

• Therapeutic Effects– Cardiac arrest– Heart Failure– Shock– A-V heart block– Kidney?

• Adverse effects– Altered HR, rhythm– Angina pectoris

Page 25: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Beta2 activation

• Therapeutic– Asthma– Preterm labor

• Adverse effects– Hyperglycemia– Tremor

Page 26: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Epinephrine

• Receptors: all alpha and beta• Therapeutic uses:

– Delay absorption of local anesthetics– Control superficial bleeding– Reduce nasal congestion– Raise BP– Mydriasis– AV block– Restart heart in cardiac arrest– Asthma– Anaphylactic shock

Page 27: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Epinephrine• Abosrption

– Inhalation: minimal– Injection

• Inactivation: MAO and COMT in liver• Adverse events

– Hypertensive crisis– Dysrythmias– Angina pectoris– Necrosis– Hyperglycemia

Page 28: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Epinephrine

• Interactoins– MAO inhibitors– Tricyclic antidepressants– Alpha-adrenergic blocking agents– Beta-adrenergic blocking agents

• Preparations– SC, IM, IV, Intracardiac, intraspinal,

inhalation,– Lidocaine with epi

Page 29: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Norepinephrine

• Receptor: alpha 1 & 2, beta1

• Therapeutic uses– Hypotensive state– Cardiac arrest

• Brand: Levophed

Page 30: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Isoprotenerenol

• Receptors: Beta1 and Beta2• Uses

– AV block– Shock– Asthma (no longer used in U.S.)– Bronchospasm (2° anesthesia)

• Adverse effects– Dysrhythmias, angina pectoris– Hyperglycemia

Page 31: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Dopamine

• Receptor: dopamine, alpha1, (beta1 high doses)

• Uses– Shock: heart and renal arteries– Heart failure– ARF: low dose (some studies call effectiveness

into question)

• Adverse Effects– Dysrhythmias, angina pectoris

Page 32: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Other Adrenergic Agonists

• Dobutamine (beta1): heart failure

• Terbutaline: (beta2):preterm labor, asthma

• Phenylephrine: (alpha1) nasal congestion

• Ephedrine (all alpha and beta):– Directly binds & ↑norepinephrine release– Nasal congestion– Narcolepsy– Can be used to make amphetamines

Page 33: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Adrenergic Antagonists

• Can be quite selective for receptors

Page 34: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Alpha1-antagogonists

• Therapeutic uses– Hypertension– BPH– Reverse toxicity of – Pheochomocytoma– Raynaud’s disease

• Adverse effects– Orthostatic

hypotension– Reflex tachycardia– Nasal Congestion– Inhibition of ejaculation– Na+ & H2O retention

Page 35: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Alpha-Adrenergic Blockers

• Prazosin - HTN

• Doxazosin – HTN, BPH

• Terazosin – HTN, BPH

• Tamsulosin – BPH

• Phentolamine – Pheochromocytoma, tissue necrosis

Page 36: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Beta-blockade

• Therapeutic Uses– Angina Pectoris– HTN– Dysrhythmias– MI– HF– Other

• Hyperthyroid• Migraine• Stage Fright• Pheochromocytoma• Glaucoma

• Adverse Effects (β1)– Bradycardia CO– Precipitate HF– AV heart block– Rebound cardiac

excitation

• Adverse Effects (β2)– Bronchoconstriction– Inhibition of

glycogenolysis

Page 37: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Beta antagonists

• Beta1, Beta2– Propanolol– Nadolol– Pindolol

• Selective– Metoprolol– Atenolol– Bisoprolol

• Beta1,beta2, alpha1– Labetalol– Carvedilol

• Used for HF– Metoprolol– Carvedilol

Page 38: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Indirect Adrenergic Antagonists

• Reserpine– Suppresses NE synthesis and promotes MAO-

mediated destruction– Crosses BBB– Effects

• Hypotension

– Adverse effects• Depression, sedation, apathy• Bradycardia, hypotension

• Guanethidine: similar but fewer CNS effect

Page 39: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Indirect Adrenergic Antagonists

• Clonidine– Causes activation of alpha-2 receptors in CNS– Uses

• Hypertension• Pain relief in cancer (epdidural use only)

– Adverse effects• Drowsiness, dry mouth, rebound HTN

– Preparations• Oral: at least twice a day• Transdermal: seven days

Page 40: Peripheral Nervous System Drugs. Cholinergic Drugs Muscarinic agonists Muscarinic antagonists Ganglionic stimulants Ganglionic blockers Neuromuscular

Indirect Adrenergic Antagonists

• Methyldopa, Methyldopate– Similar to clonidine, but are taken up in brain

stem neurons and converted to active alpha2 agonist

– Use: HTN– Adverse effects

• 10 – 20% Positive Coombs test (5%) will go on to have hemolytic anemia

• Hepatotoxicity• Drowsiness, dry mouth, hypotension, etc.